Publikationen, an denen er mitarbeitet JULIO BELARMINO BOBES GARCIA (282)

2024

  1. Anticholinergic load: A commonly neglected and preventable risk to cognition during schizophrenia treatment?

    Schizophrenia Research: Cognition, Vol. 37

  2. Aprendizaje y memoria verbal: comparación entre pacientes con trastorno por consumo de alcohol y trastorno de depresión mayor

    Adicciones: Revista de socidrogalcohol, Vol. 36, Núm. 1, pp. 21-30

  3. Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation

    Schizophrenia Bulletin, Vol. 50, Núm. 2, pp. 327-338

  4. Lithium response in bipolar disorder: Epigenome-wide DNA methylation signatures and epigenetic aging

    European Neuropsychopharmacology, Vol. 85, pp. 23-31

  5. Non-binary gender, vulnerable populations and mental health during the COVID-19 pandemic: Data from the COVID-19 MEntal health inTernational for the general population (COMET-G) study

    Journal of Affective Disorders, Vol. 352, pp. 536-551

  6. Platelet and white blood-cell-based ratios: Differential inflammatory markers of severe mental disorders?

    Spanish Journal of Psychiatry and Mental Health

  7. Processing speed mediates the relationship between DDR1 and psychosocial functioning in euthymic patients with bipolar disorder presenting psychotic symptoms

    Molecular Psychiatry, Vol. 29, Núm. 7, pp. 2050-2058

  8. PsiOvi Staging Model for Schizophrenia (PsiOvi SMS): A New Internet Tool for Staging Patients with Schizophrenia

    European Psychiatry, Vol. 67, Núm. 1

  9. Somatic multicomorbidity and disability in patients with psychiatric disorders in comparison to the general population: a quasi-epidemiological investigation in 54,826 subjects from 40 countries (COMET-G study)

    CNS Spectrums, Vol. 29, Núm. 2, pp. 126-149

2023

  1. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  2. Differential Cellular Interactome in Schizophrenia and Bipolar Disorder—Discriminatory Biomarker Role

    Antioxidants, Vol. 12, Núm. 11

  3. Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

    Psychiatry Research, Vol. 323

  4. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in depressed patients with suicidal behavior: A systematic review

    European Psychiatry

  5. Prevalence of psychological reactions and suicidal ideation during one year of the COVID-19 pandemic in patients with severe mental disorders

    Schizophrenia Research

  6. Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus

    Neurology and Therapy, Vol. 12, Núm. 2, pp. 479-503

  7. Psychological impact of the COVID-19 pandemic and lockdown in a Spanish sample with anxiety disorder: sex differences

    Actas espanolas de psiquiatria, Vol. 51, Núm. 2, pp. 65-75

  8. Results of the COVID-19 mental health international for the health professionals (COMET-HP) study: depression, suicidal tendencies and conspiracism

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 9, pp. 1387-1410

  9. The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580

  10. Tobacco use in first-episode psychosis, a multinational EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 15, pp. 7265-7276

  11. Trends in the incidence of hospital-treated suicide attempts during the COVID-19 pandemic in Oviedo, Spain

    European Psychiatry, Vol. 66, Núm. 1